"An ESOP is two tax events, two valuations, and two cash-flow problems. The 2020 deferral fixed one of them. Most employees still get caught by the other."
Quick answer
- ESOPs in India are taxed twice: as perquisite under Section 17(2)(vi) at exercise, and as capital gains under Section 45 at sale.
- Section 192(1C), inserted by the Finance Act 2020, lets employees of an "eligible startup" defer the TDS on the perquisite tax until the earliest of (a) 48 months from the end of the FY of exercise, (b) sale of the shares, or (c) exit from the company.
- "Eligible startup" is narrow: DPIIT recognition alone is not enough. The startup needs Section 80-IAC certification from the Inter-Ministerial Board. Most Indian startups do not have this.
- Deferral defers the payment, not the amount. The perquisite is still computed using FMV on the exercise date. If the share value drops later, you still pay the original tax.
- Resignation or termination ends the deferral. Plan exercises around job tenure, not around the 48-month limit alone.
Why ESOPs trip up Indian professionals
The reason ESOP taxation in India catches so many people is that it looks like RSU taxation from a distance and is structurally different up close. The basics anyone in tech, consulting, or finance knows:
- Stock vests over time, usually 4 years with a 1-year cliff.
- The company assigns a value to the stock.
- Some tax is owed at some point.
The reality is that "some tax at some point" is two distinct events with two distinct rates, computed against two distinct FMVs, with one of those events available for deferral if and only if you happen to work at a Section 80-IAC certified startup. Most other content treats this as a single event and gets the planning wrong. The math below treats it as two events explicitly.
For the equivalent regime on US-listed RSUs (Google, Microsoft, Amazon, Meta, Atlassian, etc.), the right reference is our RSU vesting + Section 17(2) tax guide. The deferral discussed here does not apply to those.
The two ESOP tax events
Event 1 - Perquisite at exercise
When you exercise an ESOP (pay the exercise price and acquire the share), the difference between the fair market value on the exercise date and the exercise price is taxed as a perquisite under Section 17(2)(vi). The perquisite is added to your salary income and taxed at your applicable slab rate.
Formally:
Perquisite value = (FMV on exercise date) - (Exercise price) - (Recovery from employee, if any)
The FMV is computed under Rule 3(8) of the Income Tax Rules:
- For listed shares: the average of the highest and lowest market price on the exercise date.
- For unlisted shares (the typical startup case): as determined by a SEBI-registered Category I merchant banker using prescribed methods (DCF being the most common), with the valuation report dated within 180 days of exercise.
For listed startups, this is mechanical. For unlisted Indian startups, the company commissions a Rule 3(8) valuation, often once a year, and pegs the FMV to that report.
Event 2 - Capital gains at sale
When you eventually sell the shares (in a buyback, secondary, tender offer, or post-IPO transaction), the gain is the difference between the sale price and the FMV used at exercise (which becomes your cost basis for capital gains purposes).
Capital gain = (Sale price) - (FMV on exercise date used as cost basis)
The character of this gain depends on holding period and whether the share is listed at the time of sale:
| Share status at sale | Holding period | Tax treatment |
|---|---|---|
| Listed on Indian stock exchange | > 12 months | LTCG at 12.5% over ₹1.25 lakh (post Budget 2024) |
| Listed on Indian stock exchange | ≤ 12 months | STCG at 20% (post Budget 2024) |
| Unlisted (buyback/secondary while private) | > 24 months | LTCG at 12.5% (indexation removed post Budget 2024) |
| Unlisted (buyback/secondary while private) | ≤ 24 months | STCG at slab rate |
Buybacks of unlisted shares from companies that have followed the Section 115QA route are treated under their own regime, with the buyback tax paid by the company; consult a CA for buyback-specific cases. The shorthand: assume two events and two tax rates, and plan accordingly.
The 2020 deferral: Section 192(1C) in plain English
Pre-2020, the perquisite tax at exercise was a hard cash problem for Indian startup employees. You exercised illiquid shares, owed slab-rate tax on the paper gain, and had no cash from the share itself to pay it. Founders and engineers often skipped exercising entirely, walking away from valuable options at exit.
The Finance Act 2020 inserted Section 192(1C) to fix this. The provision is short but precise:
The TDS on the perquisite value of ESOPs issued by an eligible startup may be deferred. The employer shall deduct or pay tax on such income within fourteen days of the earliest of the following:
(i) after the expiry of forty-eight months from the end of the relevant assessment year, or
(ii) from the date of sale of such specified security or sweat equity share, or
(iii) from the date the assessee ceases to be the employee of the person.
A few important details that are often missed:
- The 48 months are measured from the end of the relevant assessment year, not from the exercise date. For an exercise in FY 2025-26 (AY 2026-27), the 48-month clock starts on 31 March 2027 and ends on 31 March 2031. Practical horizon: roughly five years from exercise, not four.
- The deferral is on TDS, not the underlying tax liability. You do not include the perquisite in your taxable income return-by-return; it crystallises in the year the deferral ends, but the income remains attributable to the exercise year for return-of-income purposes (per the prescribed mechanism in Rule 21AAA and Schedule TI of the ITR).
- The deferral covers only the perquisite tax at Event 1. Capital gains tax at Event 2 is not deferred.
This is the bit most blog posts get wrong. Treating Section 192(1C) as a "you don't pay any ESOP tax for 48 months" line is misleading. The clock starts ticking against you the moment you exercise; the deferral is a cash-flow accommodation, not a tax break.
Who actually qualifies: the eligible-startup gate
The deferral applies only to ESOPs issued by an "eligible startup" as defined in Section 80-IAC(2)(ii) read with Section 192(1C). That definition has three cumulative conditions:
- Entity type: Private limited company or LLP. Public limited companies and partnerships are out.
- Incorporation window: Incorporated between 1 April 2016 and 31 March 2025. The Finance Act 2024 extended this from the earlier 31 March 2024 deadline. Future extensions are routine; check the latest amending Finance Act for the current window.
- Turnover cap and IMB certificate: Annual turnover up to ₹100 crore in any financial year since incorporation, and the startup must hold a certificate of eligibility from the Inter-Ministerial Board (IMB) under Section 80-IAC.
Condition 3 is the one most professionals miss. DPIIT recognition is a different administrative classification under Startup India; tens of thousands of Indian startups hold it. Section 80-IAC certification, in contrast, is granted by the IMB after a substantive review of innovation and scalability, and only a fraction of DPIIT-recognised startups apply for or receive it. As of mid-2024, the IMB had approved roughly 2,500 startups for 80-IAC, against the 100,000+ DPIIT-recognised pool.
If you cannot confirm with your employer's finance team that the company holds an IMB / 80-IAC certificate, assume you do not qualify for Section 192(1C) and plan for full perquisite tax at exercise.
A worked example at ₹50L CTC
To make the two events concrete, take a ₹50 lakh CTC engineer at a Section 80-IAC certified startup. The grant: 1,000 options at an exercise price of ₹10 per share, vesting over 4 years.
Year 4 - Exercise
- FMV (Rule 3(8) valuation) at exercise: ₹500 per share.
- Total exercise price paid: 1,000 × ₹10 = ₹10,000.
- Perquisite value: 1,000 × (₹500 - ₹10) = ₹4,90,000.
- Added to salary income in the ITR for the year of exercise.
- Marginal tax at ~30% slab (new regime, after the ₹15 lakh threshold): ~₹1,47,000 of perquisite tax.
- If eligible startup: this ₹1,47,000 of TDS is deferred under Section 192(1C). The employee still discloses the perquisite in Schedule TI but does not pay TDS at this point.
- If not eligible startup: ₹1,47,000 is deducted by the employer in the month of exercise.
Year 7 - Sale (a tender offer at ₹1,200/share, post 48-month mark or pre-mark; same analysis)
- Sale price: 1,000 × ₹1,200 = ₹12,00,000.
- Cost basis = FMV at exercise = 1,000 × ₹500 = ₹5,00,000.
- Capital gain = ₹12,00,000 - ₹5,00,000 = ₹7,00,000.
- Holding period: ~3 years post-exercise on an unlisted share → LTCG at 12.5% (post Budget 2024, indexation removed).
- LTCG tax: ~₹87,500.
- Total tax across both events: ~₹1,47,000 + ₹87,500 = ~₹2,34,500.
If the sale was within 24 months of exercise on still-unlisted shares, the gain would be short-term and taxed at slab rate (much higher, often ~30%). The holding-period planning matters more than people expect.
Common traps in ESOP planning
- Treating DPIIT recognition as 80-IAC certification. Different gates, different bars, different consequences. Always confirm with employer finance which one the company holds.
- Assuming the deferral survives a job switch. It does not. The day you resign or are terminated, the deferral ends and the employer deducts TDS on the original perquisite. Plan exercises before you start looking, or after the next role is locked.
- Waiting for the 48-month mark while shares are worthless. If the company writes down or the secondary market dries up, you still owe perquisite tax on the original FMV. The capital loss at sale is a separate event and cannot offset the perquisite tax. Be conservative on exercise sizing in earlier-stage startups.
- Forgetting Rule 3(8) valuation dates. The merchant-banker valuation must be within 180 days of the exercise date. Some startups exercise off a stale valuation; if challenged in assessment, the FMV gets reassessed and the perquisite gets adjusted.
- Confusing buyback under Section 115QA with employee capital gains. Pre-2024 buybacks of unlisted shares by Indian companies under Section 115QA were tax-free in the employee's hands (the company paid 23.296% buyback tax). The Budget 2024 amendment changed the regime: buyback proceeds are now taxed as deemed dividend in the recipient's hands at slab rate from 1 October 2024. Buyback structuring needs CA review post this change.
- Missing ITR disclosure when deferring. Even when TDS is deferred, the ESOP perquisite must be disclosed in the ITR for the year of exercise under Schedule TI (Tax Inheritance), and tax payable is computed and reported but marked as deferred. Skipping this disclosure invites a notice.
How regime selection interacts with ESOP
A common question: should you pick the new tax regime in the year you exercise? The answer is almost always yes for ₹35L+ CTC professionals, and the perquisite from ESOPs doesn't change it. The perquisite is added to salary income; the slab math then applies. In the new regime, the slab is lower at the top and the rebate threshold is higher, so a one-time perquisite bump is typically less painful. The exception: if your perquisite is very large relative to base salary (say, a ₹50 lakh ESOP perquisite on a ₹25 lakh base), it pushes you firmly into the 30% slab and the regime difference narrows. Run both numbers; see our old vs new tax regime guide for the full framework.
A practical playbook
If you have ESOPs in an Indian startup, this is the order to think in:
- Confirm 80-IAC status with employer finance, in writing. Don't infer from "Startup India recognised" copy in marketing.
- Get the Rule 3(8) FMV for the current period. This is the number that drives your perquisite at exercise.
- Model the perquisite at slab rate in the new regime, on your actual income. Add it to the regular salary, recompute. Don't average across years.
- Decide exercise sizing. Partial exercise is fine; you don't have to exercise all vested options. If 80-IAC deferral applies, the cash cost of exercise is only the exercise price (no immediate tax outflow), but the eventual liability is unchanged.
- Match exercise timing to job stability. A new-role exit terminates the deferral immediately. Exercise after you are settled, not in the months before a job switch.
- Plan capital gains horizon. For unlisted shares, hold > 24 months for LTCG. For listed, > 12 months. Track from the exercise date, not the grant date.
- Disclose properly in ITR. Schedule TI for deferred perquisite, Schedule CG for capital gains at sale, Schedule FA only if the shares are foreign (rare for Indian startup ESOPs).
The cash-flow planning is the actual content of "ESOP planning" for an Indian employee. Tax rates aside, the difference between exercising at the wrong time and the right time can swing several lakhs over the life of a grant.
Where Qubera fits
Qubera tracks ESOP grants alongside RSU and ESPP positions, models the perquisite at exercise against your current-year slab, flags 80-IAC eligibility, and runs the holding-period clock for LTCG planning. The companion approach matters here because ESOP planning is not an annual event but a continuous one: vesting dates, valuation refresh, secondary windows, and job tenure all feed into the optimal exercise schedule. The math is identical whether you do it in a spreadsheet or in an AI personal finance companion for India; the maintenance loop is what makes it work.
For the RSU-equivalent treatment (US-listed grants, Schedule FA, Foreign Tax Credit), see our RSU vesting and Section 17(2) guide. For the broader playbook the ESOP decision sits inside, see Money management for young Indian earners.